Valuation: Kenvue Inc.

Market Cap 37.54B 32.59B 30.39B 27.92B 52.8B 3,571B 53.38B 358B 140B 1,785B 141B 138B 5,914B P/E 2026 *
20.6x
P/E 2027 * 18.2x
Enterprise Value 44.94B 39.02B 36.38B 33.42B 63.21B 4,275B 63.91B 429B 168B 2,137B 169B 165B 7,081B EV / Sales 2026 *
2.88x
EV / Sales 2027 * 2.77x
Free-Float
98.9%
Yield 2026 *
4.33%
Yield 2027 * 4.42%
1 day+2.84%
1 week-1.01%
Current month+1.61%
1 month-1.41%
3 months+13.99%
6 months+8.55%
Current year+13.33%
1 week 18.68
Extreme 18.685
19.77
1 month 18.58
Extreme 18.58
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
21.96
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
2/13/26 Fiscal year

Chief Operating Officer

64,111 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+2.84%-1.01%-11.86%-16.91% 37.54B
+2.10%-0.58%-1.82%-4.68% 345B
+0.49%-4.21%-5.81%+3.79% 137B
+2.95%-0.22%+11.00%+21.33% 73.76B
-0.89%-1.92%-18.05%-19.15% 51.78B
+2.70%+2.62%-5.98%-49.04% 31.47B
+2.57%-1.88%-24.73%-32.35% 19.68B
+1.05%+0.04%+15.03%+8.72% 19.68B
-0.87%-6.76%-6.50%+12.73% 18.47B
+0.66%-1.07%-12.66%+3.33% 11.38B
Average +1.09%-1.06%-6.14%-7.22% 74.59B
Weighted average by Cap. +0.47%-1.97%-3.54%-3.86%

Financials

2026 *2027 *
Net sales 15.63B 13.57B 12.65B 11.62B 21.98B 1,486B 22.22B 149B 58.3B 743B 58.68B 57.39B 2,462B 16.01B 13.9B 12.96B 11.91B 22.52B 1,523B 22.77B 153B 59.74B 761B 60.13B 58.81B 2,523B
Net income 1.83B 1.59B 1.48B 1.36B 2.57B 174B 2.6B 17.47B 6.83B 87.03B 6.87B 6.72B 288B 2.07B 1.8B 1.68B 1.54B 2.91B 197B 2.94B 19.77B 7.73B 98.47B 7.78B 7.61B 326B
Net Debt 7.41B 6.43B 6B 5.51B 10.42B 705B 10.53B 70.69B 27.63B 352B 27.81B 27.2B 1,167B 6.81B 5.91B 5.51B 5.07B 9.58B 648B 9.69B 65.01B 25.41B 324B 25.58B 25.02B 1,073B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-08-04 US$19.55 +2.84% 23,595,514
26-08-03 US$19.01 -1.20% 35,167,488
26-07-31 US$19.24 -0.36% 22,744,382
26-07-30 US$19.31 -2.43% 16,297,221
26-07-29 US$19.79 +0.20% 27,193,670
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.55USD
Average target price
19.83USD
Spread / Average Target
+1.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock